688238 和元生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资67,3100.58%66,92242,22415,84617,099
投资性房地产0--0000
固定资产1,355,16529.57%1,045,863197,84190,94355,189
在建工程68,528-80.21%346,324573,006191,77814,073
无形资产54,647-1.52%55,49251,29452,22151,462
商誉0--0000
其他非流动资产159,132-1.43%161,441167,386168,15463,538
1,704,7811.71%1,676,0421,031,751518,943201,360

流动资产
货币资金486,008-26.03%657,0481,243,842619,007455,356
应收账款68,000-1.73%69,20077,80928,83223,524
存货82,8892.52%80,84965,64744,03522,207
其他流动资产140,83617.02%120,35377,42252,621245,789
777,734-16.14%927,4501,464,720744,495746,876

流动负债
短期借款60,040--0000
应付票据196--000947
应付帐款186,430-18.41%228,502119,23749,67814,639
其他流动负债77,319-9.75%85,66967,69686,84056,307
323,9843.12%314,171186,934136,51871,893
流动资产净值453,750-26.01%613,2791,277,786607,977674,983
资产总额减流动负债2,158,531-5.71%2,289,3212,309,5371,126,920876,343

非流动负债
长期借款135,505-6.04%144,22244,406101,4010
应付债券0--0000
其他非流动负债79,752-8.05%86,73193,429107,85226,894
215,257-6.80%230,953137,835209,25326,894

总权益
    实收股本647,4330.00%647,433493,189393,189393,189
    储备项目1,295,974-8.14%1,410,8101,678,513524,478456,261
股东权益1,943,407-5.58%2,058,2432,171,702917,667849,450
非控股权益(132)-205.60%125000